Dexrazoxane

Results: 6



#Item
12?-JUN-241.L  DEPT OF HERLTH 1_6129

2?-JUN-241.L DEPT OF HERLTH 1_6129

Add to Reading List

Source URL: www.hkam.org.hk

Language: English - Date: 2014-02-19 00:50:58
2Topoisomerase 2β: A Promising Molecular Target for Primary Prevention of Anthracycline-Induced Cardiotoxicity

Topoisomerase 2β: A Promising Molecular Target for Primary Prevention of Anthracycline-Induced Cardiotoxicity

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2014-02-03 14:11:16
3Doxorubicin Hydrochloride Injection, USP HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Doxorubicin Hydrochloride Injection, USP

Doxorubicin Hydrochloride Injection, USP HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Doxorubicin Hydrochloride Injection, USP

Add to Reading List

Source URL: www.sagentpharma.com

Language: English - Date: 2014-09-26 12:31:09
4CATALOG  DOXORUBICIN Differentiated Packaging on Vials and Cartons Labels are DistinctIV

CATALOG DOXORUBICIN Differentiated Packaging on Vials and Cartons Labels are DistinctIV

Add to Reading List

Source URL: www.sagentpharma.com

Language: English - Date: 2014-09-26 12:31:06
5Zinecard®  (dexrazoxane for injection) DESCRIPTION ZINECARD® (dexrazoxane for injection) is a sterile, pyrogen-free lyophilizate intended

Zinecard® (dexrazoxane for injection) DESCRIPTION ZINECARD® (dexrazoxane for injection) is a sterile, pyrogen-free lyophilizate intended

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-07-13 10:19:53
6ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2013-07-21 05:37:09